In this age of molecular biology and armed with new understandings about the role that genes play in pancreatic cancer, familial registries are increasingly seen as a powerful resource to gain a better understanding of the disease – and hence better detection or treatment possibilities. We have been able to identify several cancer registries worldwide that are specific to or involve pancreatic cancer. If you know of a pancreatic cancer registry which is not included in the list below, please let us know.

Regular giving can be an opportunity to pay tribute in honour of a loved one. Your monthly gift will go directly to promoting awareness, increasing education, furthering pancreatic cancer research aimed at early diagnosis and, helping patients and families impacted by the effects of pancreatic cancer.

Simply select “Monthly” after choosing the amount you would like to give on the donation form.

To Safely make a Donation via Text, Text the Code FIGHTPC to number 44-321

Making IMPACT for Pancreatic Cancer Together!

Join our expanding community on Facebook! Connect with others, share stories, and get support!Click Here

MONTHLY MEMORIAL GIFTS: YOUR TRIBUTE TO A LOVED ONE

Regular giving can be an opportunity to pay tribute in honour of a loved one. Your monthly gift will go directly to promoting awareness, increasing education, furthering pancreatic cancer research aimed at early diagnosis and, helping patients and families impacted by the effects of pancreatic cancer.

Simply select “Monthly” after choosing the amount you would like to give.

Genetic Testing for Pancreatic Cancer

PROPOSED: Every newly diagnosed person with pancreatic cancer (ductal adenocarcinoma of the pancreas) should receive genetic screening prior to beginning treatment – to test for germline genetic mutations in the homologous recombination DNA repair pathway, including genes such as BRCA1, BRCA2, PALB2, and others. These results, in from 12% to 17% of pancreatic cancer patients, suggest that treatment that includes DNA cross-linking agents such as platinum compounds or PARP inhibitors may be superior to standard best practices therapy.

OFFER: Color Genomics offers a 30-gene cancer panel for $224 (normally $249) when the Promotion Code “PANCREATIC” is entered at checkout (price will reduce upon entering this code). This is a physician-ordered saliva kit. Click Here for more information

RATIONALE: The age of precision medicine in pancreatic cancer is approaching … [MORE]

This year an estimated 57,600 Americans will be diagnosed with pancreatic cancer. Approximately 47,050 Americans are expected to die from the disease. There are many reasons why the outcome for pancreatic cancer patients is bleaker than for most other cancer types. There are no reliable methods to detect the disease early, and there are very few effective treatment options. Which is why we are so focused on supporting research for early diagnosis.

Together with You our Mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.

Most of our fundraisers, supporters, and volunteers, have been in one way or another, personally effected by this disease. We want to acknowledge what hardships you may have gone through (or are currently facing) and sincerely thank you for visiting our site!

Walk, Run, or Choose your own!

Choose a walk, run, or any other activity that you like and work to raise donations leading up to your Event! Simply set up your participation page and we will be in touch!

Cancer Patients Alliance is a 501(c)(3) non-profit. Initiatives include, ToFightCancer.com and Pancreatica.org. All Donations are tax-deductible.

Pancreatic cancer is expected to become the 2nd leading cause of cancer-related death by the year 2020. There are many reasons why the outcome for pancreatic cancer patients is much bleaker than for most other cancer types. There are no reliable methods to detect the disease early, and there are very few effective treatment options.

There remains a dire need for more research and an increase in focused funding for pancreatic cancer. Your Donation will go directly to promoting awareness, increasing education, and furthering pancreatic cancer research aimed at early diagnosis.

Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to help fight pancreatic cancer!AmazonSmile is the same Amazon you know. Same products, same prices, same service. Simply use our Link to start shopping!

"It was such an awesome experience for our whole family to be given the opportunity to participate in such a great and meaningful Walk!”

"The weekend was absolutely amazing
and inspiring!! I had a fantastic time raising funds for this charity."

“This charity is focused on directly supporting the kind of research I want to support. Research to diagnosis pancreatic cancer at an earlier stage. They have also helped my family find a genetics center for screening”

"This weekend was so amazing, seeing all those people come together for this cause was inspiring."

Why Choose Cancer Patients Alliance?
“This charity is focused on directly supporting the kind of research I want to support. Research to diagnosis pancreatic cancer at an earlier stage. They have also helped my family find a genetics center for screening”
~ Anne Friedrich
“We ran a 5K in honor of our grandmother June, Cancer Patients Alliance gave us great resources, information, and encouragement”

"Thanks for the great organization and I look forward to walking or running in the future to help this cause."

Cancer Patients Alliance's websites have been an amazing resource for my family. The medical literature references displays an impressive concentration of information on published scientific articles. I will continue to support and volunteer with this great charity and cause.

Previous

Next

Speak with a Survivor:

Call 1-800-433-0464 for a free service that will place you in contact with a fellow survivor, or to volunteer to contact someone more recently diagnosed.

Pancreatic Cancer Blog

One of the observations that physicians often made when the standard of care treatment typically consisted of the chemotherapy drug agent of gemcitabine alone, was that many patients with pancreatic cancer (ductal adenocarcinoma of the pancreas) seemed to feel better after the initiation of treatment… More Here